Zhu L - Search Results

1

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44.

Dohadwala M, Luo J, Zhu L, Lin Y, Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM. Dohadwala M, et al. Among authors: zhu l. J Biol Chem. 2001 Jun 15;276(24):20809-12. doi: 10.1074/jbc.C100140200. Epub 2001 Apr 24. J Biol Chem. 2001. PMID: 11320076 Free PMC article.

2

Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells.

Heuze-Vourc'h N, Zhu L, Krysan K, Batra RK, Sharma S, Dubinett SM. Heuze-Vourc'h N, et al. Among authors: zhu l. Cancer Res. 2003 Feb 15;63(4):766-70. Cancer Res. 2003. PMID: 12591723

3

Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.

Sharma S, Stolina M, Yang SC, Baratelli F, Lin JF, Atianzar K, Luo J, Zhu L, Lin Y, Huang M, Dohadwala M, Batra RK, Dubinett SM. Sharma S, et al. Among authors: zhu l. Clin Cancer Res. 2003 Mar;9(3):961-8. Clin Cancer Res. 2003. PMID: 12631593

4

COX-2-dependent stabilization of survivin in non-small cell lung cancer.

Krysan K, Merchant FH, Zhu L, Dohadwala M, Luo J, Lin Y, Heuze-Vourc'h N, Põld M, Seligson D, Chia D, Goodglick L, Wang H, Strieter R, Sharma S, Dubinett S. Krysan K, et al. Among authors: zhu l. FASEB J. 2004 Jan;18(1):206-8. doi: 10.1096/fj.03-0369fje. Epub 2003 Nov 3. FASEB J. 2004. PMID: 14597555

5

Cyclooxygenase-2-dependent expression of survivin in non-small cell lung cancer.

Krysan K, Dohadwala M, Luo J, Lin Y, Zhu L, Heuze-Vourc'h N, Goodglick L, Merchant F, Seligson D, Pold M, Strieter R, Sharma S, Dubinett S. Krysan K, et al. Among authors: zhu l. Chest. 2004 May;125(5 Suppl):140S. doi: 10.1378/chest.125.5_suppl.140s. Chest. 2004. PMID: 15136466 No abstract available.

6

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.

Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F, Huang M, Batra RK, Dubinett SM. Sharma S, et al. Among authors: zhu l. Cancer Res. 2005 Jun 15;65(12):5211-20. doi: 10.1158/0008-5472.CAN-05-0141. Cancer Res. 2005. PMID: 15958566

7

Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses.

Sharma S, Zhu L, Yang SC, Zhang L, Lin J, Hillinger S, Gardner B, Reckamp K, Strieter RM, Huang M, Batra RK, Dubinett SM. Sharma S, et al. Among authors: zhu l. J Immunol. 2005 Jul 15;175(2):813-9. doi: 10.4049/jimmunol.175.2.813. J Immunol. 2005. PMID: 16002678

8

Methanandamide increases COX-2 expression and tumor growth in murine lung cancer.

Gardner B, Zhu LX, Sharma S, Tashkin DP, Dubinett SM. Gardner B, et al. FASEB J. 2003 Nov;17(14):2157-9. doi: 10.1096/fj.03-0254fje. Epub 2003 Sep 4. FASEB J. 2003. PMID: 12958151

9

Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.

Põld M, Zhu LX, Sharma S, Burdick MD, Lin Y, Lee PP, Põld A, Luo J, Krysan K, Dohadwala M, Mao JT, Batra RK, Strieter RM, Dubinett SM. Põld M, et al. Cancer Res. 2004 Mar 1;64(5):1853-60. doi: 10.1158/0008-5472.can-03-3262. Cancer Res. 2004. PMID: 14996749

10

Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma.

Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, Magyar CE, Dohadwala M, Lee JM, St John MA, Strieter RM, Sharma S, Dubinett SM. Yanagawa J, et al. Among authors: zhu lx. Clin Cancer Res. 2009 Nov 15;15(22):6820-9. doi: 10.1158/1078-0432.CCR-09-1558. Epub 2009 Nov 3. Clin Cancer Res. 2009. PMID: 19887480 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27,329 results

Search Page